Akèy › Anplwayè › Cerevel Therapeutics, LLC
Cerevel Therapeutics, LLC: Salè H-1B ak pajon
Cerevel Therapeutics, LLC depoze 7 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 7. Medyèn salè yo ofri a: $139,000.
Èske Cerevel Therapeutics, LLC pajone visa H-1B?
Cerevel Therapeutics, LLC depoze 7 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jul 12, 2024. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Principal Analyst, Clinical Programming | 2 | $139,500 |
| Principal Scientist, Formulation Development | 2 | $130,500 |
| Senior Director, Medical Affairs | 1 | $300,000 |
| Senior Manager, Clinical Pharmacology | 1 | $180,000 |
| Research Scientist, Formulation Development | 1 | $120,119 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $159,500 |
| FY2024 | 3 | $130,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Chemists3
- Molecular and Cellular Biologists2
- Medical and Health Services Managers1
- Medical Scientists, Except Epidemiologists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Principal Scientist, Formulation Development | $130,000–$166,000 Nivo IV | Somerset, NJ | Jul 12, 2024 | Jul 29, 2024 | Certifye |
| Principal Analyst, Clinical Programming | $140,000–$163,000 Nivo III | Larenceville, NJ | Jun 4, 2024 | Jun 17, 2024 | Certifye |
| Research Scientist, Formulation Development | $120,119–$138,000 | Cambridge, MA | Apr 24, 2024 | Oct 1, 2024 | Certifye |
| Senior Manager, Clinical Pharmacology | $180,000–$191,113 Nivo IV | Cambridge, MA | Jun 28, 2023 | Jul 17, 2023 | Certifye |
| Principal Analyst, Clinical Programming | $139,000–$164,000 Nivo III | Cambridge, MA | Mar 17, 2023 | Apr 10, 2023 | Certifye |
| Principal Scientist, Formulation Development | $131,000–$168,000 Nivo III | Cambridge, MA | Dec 26, 2022 | Jan 30, 2023 | Certifye |
| Senior Director, Medical Affairs | $300,000–$350,000 Nivo IV | Cambridge, MA | Jun 30, 2022 | Jul 18, 2022 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).